Combined aclidinium bromide and long-acting beta2 -agonist for COPD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined aclidinium bromide and long-acting beta2 -agonist for COPD

Published:2015-03-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ni Han¹,Moe Soe²,Soe Zay³,Myint Kay Thi⁴,Viswanathan K Neelakantan¹

Affiliation:

1. SEGi University; Internal Medicine; Hospital Teluk Intan Jalan Changkat Jong Teluk Intan Perak Darul Ridzuan Malaysia 36000

2. Melaka-Manipal Medical College; Community Medicine; Jalan Batu Hampar Bukit Baru Melaka Malaysia 75150

3. UCSI University; Internal Medicine; Terengganu Malaysia

4. Faculty of Medicine, SEGi University; Ophthalmology; Sibu Sarawak Malaysia 96000

Publisher

Wiley

Subject

Pharmacology (medical)

Reference61 articles.

1. Almirall Clinical trials registry and results http://www.almirall.com/en/about-almirall/research-and-development/clinical-trials

2. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease;Appleton;Cochrane Database of Systematic Reviews,2006

3. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society;Qaseem;Annals of Internal Medicine,2011

4. Chronic obstructive pulmonary disease;Barnes;The New England Journal of Medicine,2000

5. The influence of cigarette smoking on viral infections: translating bench science to impact COPD pathogenesis and acute exacerbations of COPD clinically;Bauer;Chest,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD);Cochrane Database of Systematic Reviews;2017-06-20

2. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD);Cochrane Database of Systematic Reviews;2015-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3